FDA backs off oyster ban amid GOP and industry backlash
The FDA paused a plan to bar raw Gulf of Mexico oysters during warm months after critics argued the move would devastate a $500 million industry and cost thousands of jobs. Supporters urged safer processing, while opponents said pasteurization harms taste and texture.
MENTIONED IN THIS ARTICLE
Washington, D.C
Gulf of Mexico
Food and Drug Administration
Gulf
U.S
FDA
The
Mike Voisin
Houma
Chrysler
Voisin
Kevin Begos
Franklin County
Oyster & Seafood Task Force
Apalachicola
Fla
Julius Steel
Pascal’s
Manale
New Orleans
FDA finds particles in Genzyme drugs prompting caution
U S federal regulators detected tiny bits of steel rubber and fiber in Genzyme vials used to treat rare enzyme disorders warning that such contamination could cause serious health effects. The agency kept the drugs on the market and urged doctors to inspect vials and return suspected lots. Genzyme shares fell as FDA notes contamination likely affects about 1 percent of products with no reported adverse events.
MENTIONED IN THIS ARTICLE
Washington, D.C
Genzyme
Biotechny Company
Food and Drug Administration
FDA
Genzyme Corp
Cambridge
Cerezyme
Fabrazyme
Allston Landing
Mass
Jason Woo
FDA pressures makers of caffeinated alcoholic drinks
The FDA is demanding evidence that caffeine chilled alcoholic beverages are safe, sending letters to 30 manufacturers with a 30 day deadline. The move follows calls from state attorneys general who say the drinks lure youth and mask intoxication, risking traffic accidents and violence.
MENTIONED IN THIS ARTICLE
Washington, D.C
Food and Drug Administration
FDA
Joshua Sharf Stein
Joose
Charge
Mike Taylor
New
York
California
Maryland
Red Bull
Anheuser-isusch
Joose Beverage
Portland
Ore
Also Mentioned on This Page
E. Walker Crosby
Huntsman Dr
Country Square
Aikenwalkercrot
Lstate.com
el Allstate
Yance
CSRA
Quality Heating & Cooling
Werner
Aked
Aiken
Whiskey Road
Centre South
Silver Bluff Rd